Risk Of Developing Liver Cancer After HCV Treatment

▼
Showing posts with label Peginterferon. Show all posts
Showing posts with label Peginterferon. Show all posts
Tuesday, February 11, 2014

Hepatitis C-Antidepressants for prevention of Interferon-associated depression

›
International Journal of Clinical Practice Prevention of Interferon-Alpha-Associated Depression With Antidepressant Medications in Patient...
Wednesday, January 22, 2014

Neutropenia-Lymphocyte count associated with infection risk during HCV interferon treatment

›
Lymphocyte count associated with infection risk during interferon treatment Melia M. Clin Infect Dis. 2014;doi:10.1093/cid/ciu009. Adu...
Monday, November 11, 2013

Gender-Oriented Analysis: Who Is More Likely to Respond To Dual Therapy W-PEG-IFN/RBV For Hepatitis C?

›
  Who Is More Likely to Respond to Dual Treatment With Pegylated-Interferon and Ribavirin for Chronic Hepatitis C? A Gender-Oriented Analy...
Saturday, July 27, 2013

Fever after interferon injection for HCV predicts treatment success

›
Fever after interferon injection for HCV predicts treatment success Last Updated: 2013-07-25 15:20:15 -0400 (Reuters Health) By Will Bog...
Wednesday, June 12, 2013

Noncompliance with guidelines 'stop rules' for the treatment of hepatitis C is frequent in daily practice.

›
Eur J Gastroenterol Hepatol. 2013 Jun 6. [Epub ahead of print] Noncompliance with guidelines for the treatment of hepatitis C is frequent...
Tuesday, May 7, 2013

Early HCV Response More Likely With Peg-Interferon Alpha-2a Than -2b

›
Pegasys (Peginterferon alfa-2a )..Peg-Intron (Peginterferon alfa-2b)   Reuters Health Information   Early HCV Response More Likely W...
Monday, April 1, 2013

Type 1 Diabetes Mellitus with Dual Autoimmune Mechanism Related to Pegylated Interferon and Ribavirin Treatment for Chronic HCV Hepatitis

›
Type 1 Diabetes Mellitus with Dual Autoimmune Mechanism Related to Pegylated Interferon and Ribavirin Treatment for Chronic HCV Hepatitis...
Thursday, March 7, 2013

Peg-Interferon Plus Ribavirin Safe, Modestly Effective for HCV in Kidney Recipients

›
By Will Boggs, MD NEW YORK (Reuters Health) Mar 05 - In kidney transplant recipients with chronic hepatitis C, pegylated interferon plus rib...
Thursday, February 21, 2013

Peg-Interferon and Ribavirin in HCV Compensated Cirrhosis

›
Role of IL-28B and Inosine Triphosphatase Polymorphisms in Efficacy and Safety of Peg-Interferon and Ribavirin in Chronic Hepatitis C Compen...
Friday, February 15, 2013

Incident anemia improved response to peginterferon, ribavirin, boceprevir in HCV patients

›
Incident anemia improved response to peginterferon, ribavirin, boceprevir in HCV patients Sulkowski MS. Hepatology . 2013;doi:10.1002/hep....
Thursday, February 14, 2013

Vitamin A deficiency reduced response to therapy for chronic HCV

›
Vitamin A deficiency reduced response to therapy for chronic HCV Bitetto D. Hepatology. 2013;doi:10.1002/hep.26186. February 14, 2013 Vita...
Tuesday, January 29, 2013

Pegylated interferon- Pegasys, PegIntron similarly effective for chronic HCV genotype 1

›
*pegylated interferon alfa-2a (Pegasys) and alfa-2b ( PegIntron) Pegylated interferon alfa-2a, 2b similarly effective for chronic HCV gen...
Thursday, January 24, 2013

One in Six Chronic Hepatitis C Patients May Have a Contraindication to Standard Treatment

›
One in Six Chronic Hepatitis C Patients May Have a Contraindication to Standard Treatment By Will Boggs, MD NEW YORK (Reuters Health) Jan...
Thursday, December 27, 2012

Retreatment with peginterferon alfa and ribavirin in patients with chronic viral hepatitis C genotype 2 and 3

›
Research article The effectiveness of retreatment with peginterferon alfa and ribavirin in patients with chronic viral hepatitis C genoty...